Braslyn Ltd.
CIK 1642355 · last filed 2024-01-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.39M
Companies
3
Total Filings
22
Lifetime Open-Market Net
-$228.18M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 3,135,557 | $58.70 | $184.06M | -$269.37M | 19 | 2021-03-10 |
| INSG | 10%+ Owner | 761,483 | $7.08 | $5.39M | -$36.81M | 1 | 2020-12-16 |
| Pandion Therapeutics, Inc. (PAND) Delisted | 10%+ Owner | 1,408,913 | $60.05 | $84.61M | $78.00M | 1 | 2020-07-21 |
Recent Filings · Page 2 of 3
22 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-25 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +77,533 | $414.6K | EDGAR |
| 2017-01-20 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +61,158 | $334.0K | EDGAR |
| 2017-01-17 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +119,887 | $658.9K | EDGAR |
| 2017-01-10 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +581,870 | $3.26M | EDGAR |
| 2016-06-08 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +376,902 | $3.75M | EDGAR |
| 2016-05-09 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +65,782 | $1.20M | EDGAR |
| 2016-03-31 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +3,400 | $64.9K | EDGAR |
| 2016-03-28 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +20,848 | $403.7K | EDGAR |
| 2016-03-22 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +1,166 | $22.6K | EDGAR |
| 2016-03-17 | Mirati Therapeutics, Inc. (MRTX) Delisted | Other (J) | +375,298 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.